From emergency to security: Healthcare collaboration in the post-Covid world

New research reveals that the urgency of combating Covid-19 drove closer collaboration between biopharma and government.

Better rules make better relationships

Covid-19 forced governments and biopharma companies to work together more than ever before, and at unprecedented speed, to approve products for the public good.

Growth beyond crisis: How can governments help their biopharma sectors to thrive?

From rapidly accelerated development and manufacturing to improved public-private sector collaboration, the impact of the pandemic on the biopharma sector has been nothing short of phenomenal.